Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

Tylenol, Advil battle heading to FTC

Published on .

Unable to resolve the ongoing ad battle between Johnson & Johnson and archrival American Home Products Corp.--now over a J&J Extra Strength Tylenol spot about how ibuprofen aggravates ulcers--the National Advertising Division of the Council of Better Business Bureaus referred the case to the Federal Trade Commission. NAD said J&J challenged its jurisdiction and "would not participate in the self regulatory process." The spot, from Saatchi & Saatchi's Healthcare Connection, stopped running in March.

Most Popular
In this article: